STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLSD
  4. [EFFECT] Clearside Biomedical, Inc. SEC Filing

[EFFECT] Clearside Biomedical, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 16, 2025
Accession Number: 0001193125-25-319161
Submission Type: POS AM
CIK: 0001539029
Company Name: Clearside Biomedical, Inc.
File Number: 333-271902

Source: View Original Filing on SEC EDGAR

Stock CLSD logo
Clearside Biomed

NASDAQ:CLSD

CLSD Rankings

#6814 Ranked by Market Cap
N/A Ranked by Dividends

CLSD Latest News

Nov 24, 2025
Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
Aug 26, 2025
Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress
Jul 23, 2025
Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada
Jul 17, 2025
Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline
Jun 17, 2025
Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting

CLSD Latest SEC Filings

Dec 15, 2025
[POS AM] Clearside Biomedical, Inc. SEC Filing
Dec 17, 2025
[EFFECT] Clearside Biomedical, Inc. SEC Filing
Nov 25, 2025
[8-K] Clearside Biomedical, Inc. Reports Material Event
Nov 14, 2025
[10-Q] Clearside Biomedical, Inc. Quarterly Earnings Report
Oct 7, 2025
[8-K] Clearside Biomedical, Inc. Reports Material Event

CLSD Stock Data

2.15M
4.56M
12.88%
14.87%
2.19%
Biotechnology
Pharmaceutical Preparations
Link
United States
ALPHARETTA